MedPath

Effectiveness and Safety of Korean Medicine for Lumbar Stenosis Patients With Sciatica

Terminated
Conditions
Lumbar Spinal Stenosis
Interventions
Drug: Herbal medicine
Procedure: Chuna manipulation
Procedure: Bee venom pharmacopuncture
Procedure: Pharmacopuncture
Procedure: Acupuncture
Procedure: Electroacupuncture
Procedure: Cupping
Other: Other intervention(s)
Registration Number
NCT02975011
Lead Sponsor
Jaseng Medical Foundation
Brief Summary

A prospective study investigating the effectiveness and safety in lumbar stenosis patients receiving integrative Korean medicine treatment at 3 locations of Jaseng Hospital of Korean Medicine through assessment of pain, functional disability, and quality of life

Detailed Description

This is a prospective study to the aim of investigating the effectiveness and safety in patients with neurogenic claudication diagnosed as lumbar stenosis by lumbar MRI and receiving integrative Korean medicine treatment (herbal medicine, Chuna manipulation, bee venom pharmacopuncture and pharmacopuncture, acupuncture, electroacupuncture, and cupping) at 3 locations of Jaseng Hospital of Korean Medicine (Bucheon, Daejeon, Busan (Haeundae)) through assessment of pain, functional disability, and quality of life with 1-year follow-up period

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
38
Inclusion Criteria
  • Patients with radiating leg pain with or without low back pain (LBP) (walking pain NRS ≥4)
  • Patients with dural sac cross-sectional area (DSCA) of <100 mm2 or morphological grading ≥B as assessed on MRI
  • Patients with clear neurogenic claudication symptoms (symptoms aggravated with walking, and alleviated upon resting in lumbar flexion position)
  • Patients who have received surgery recommendation for lumbar spinal stenosis
  • Patients with plans of receiving Korean medicine treatment for lumbar spinal stenosis for ≥2 months
  • Patients who have agreed to study participation
Exclusion Criteria
  • Patients with vascular claudication
  • Patients with other systemic diseases that may interfere with treatment effect or outcome interpretation
  • Patients with soft tissue pathologies or pathologies of non-spinal origin that may cause LBP or radiating leg pain (e.g. spinal tumor, rheumatoid arthritis)
  • Patients for whom acupuncture treatment may be inappropriate or unsafe (e.g. hemorrhagic diseases, blood clotting disorders, history of anti-coagulation medicine intake, serious diabetes with risk of infection, severe cardiovascular diseases, or other conditions deemed unsuitable for acupuncture treatment)
  • Pregnant patients or patients planning pregnancy
  • Patients with serious psychological disorders
  • Patients unable to fill out study participation consent form
  • Subjects deemed unsuitable for study participation as assessed by the researchers

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Lumbar stenosis groupHerbal medicineLumbar stenosis patients will be administered integrative Korean medicine treatment consisting of herbal medicine, Chuna manipulation, bee venom pharmacopuncture and pharmacopuncture, acupuncture, electroacupuncture, cupping, and other interventions, as needed.
Lumbar stenosis groupChuna manipulationLumbar stenosis patients will be administered integrative Korean medicine treatment consisting of herbal medicine, Chuna manipulation, bee venom pharmacopuncture and pharmacopuncture, acupuncture, electroacupuncture, cupping, and other interventions, as needed.
Lumbar stenosis groupBee venom pharmacopunctureLumbar stenosis patients will be administered integrative Korean medicine treatment consisting of herbal medicine, Chuna manipulation, bee venom pharmacopuncture and pharmacopuncture, acupuncture, electroacupuncture, cupping, and other interventions, as needed.
Lumbar stenosis groupPharmacopunctureLumbar stenosis patients will be administered integrative Korean medicine treatment consisting of herbal medicine, Chuna manipulation, bee venom pharmacopuncture and pharmacopuncture, acupuncture, electroacupuncture, cupping, and other interventions, as needed.
Lumbar stenosis groupAcupunctureLumbar stenosis patients will be administered integrative Korean medicine treatment consisting of herbal medicine, Chuna manipulation, bee venom pharmacopuncture and pharmacopuncture, acupuncture, electroacupuncture, cupping, and other interventions, as needed.
Lumbar stenosis groupElectroacupunctureLumbar stenosis patients will be administered integrative Korean medicine treatment consisting of herbal medicine, Chuna manipulation, bee venom pharmacopuncture and pharmacopuncture, acupuncture, electroacupuncture, cupping, and other interventions, as needed.
Lumbar stenosis groupCuppingLumbar stenosis patients will be administered integrative Korean medicine treatment consisting of herbal medicine, Chuna manipulation, bee venom pharmacopuncture and pharmacopuncture, acupuncture, electroacupuncture, cupping, and other interventions, as needed.
Lumbar stenosis groupOther intervention(s)Lumbar stenosis patients will be administered integrative Korean medicine treatment consisting of herbal medicine, Chuna manipulation, bee venom pharmacopuncture and pharmacopuncture, acupuncture, electroacupuncture, cupping, and other interventions, as needed.
Primary Outcome Measures
NameTimeMethod
Change in Numeric rating scale (NRS) of low back painChange from baseline to 3 months

Change in low back pain intensity

Change in Numeric rating scale (NRS) of radiating leg painChange from baseline to 3 months

Change in radiating leg pain intensity

Secondary Outcome Measures
NameTimeMethod
Numeric rating scale (NRS) of low back painBaseline, 1, 2, 3, 6, 12 months

Low back pain intensity for the past 3 days

Physical examinationBaseline, 1, 2, 3 months

Lumbar physical examination

Pain-free walking timeBaseline, 1, 2, 3, 6, 12 months

Average pain-free walking time for the past 3 days

Numeric rating scale (NRS) of radiating leg painBaseline, 1, 2, 3, 6, 12 months

Radiating leg pain intensity for the past 3 days

Oswestry Disability Index (ODI)Baseline, 1, 2, 3, 6, 12 months

Functional disability questionnaire

EuroQol 5-dimensions 5-levels (EQ-5D-5L)Baseline, 1, 2, 3, 6, 12 months

Health-related quality of life questionnaire

Current medical service useBaseline, 1, 2, 3, 6, 12 months

Current use of medical services (type, frequency, period)

Patient Global Impression of Change (PGIC)6, 12 months

Global patient-reported outcome

Trial Locations

Locations (1)

Jaseng Medical Foundation

🇰🇷

Seoul, Korea, Republic of

Jaseng Medical Foundation
🇰🇷Seoul, Korea, Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.